A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Breast Cancer

NCT07483307 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

176

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
HER2-negative Breast Cancer
HER2 Negative Breast Carcinoma
ER+ Breast Cancer

Interventions

DRUG: Neoadjuvant endocrine therapy

Sponsor

Memorial Sloan Kettering Cancer Center